Amedeo's Top 20

Amedeo Smart

Independent Medical Education


05 September 2022

Multidisciplinary Journal Club

  1. Steinman L, Fox E, Hartung HP, Alvarez E, et al.
    Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
    N Engl J Med 2022;387:704-714.

  1. Chou R, Cantor A, Dana T, Wagner J, et al.
    Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA 2022;328:754-771.

  2. Schmitz T, Doret-Dion M, Sentilhes L, Parant O, et al.
    Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial.
    Lancet 2022;400:592-604.

  3. Castellano JM, Pocock SJ, Bhatt DL, Quesada AJ, et al.
    Polypill Strategy in Secondary Cardiovascular Prevention.
    N Engl J Med 2022.

  4. Tesfaye S, Sloan G, Petrie J, White D, et al.
    Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, doub
    Lancet 2022.

  1. Kagujje M, Kerkhoff AD, Nteeni M, Dunn I, et al.
    The performance of computer-aided detection digital chest X-ray reading technologies for triage of active Tuberculosis among persons with a history of previous Tuberculosis.
    Clin Infect Dis 2022.

  2. Solomon SD, McMurray JJV, Claggett B, de Boer RA, et al.
    Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
    N Engl J Med 2022.

  3. Uldall Torp NM, Bruun NH, Christensen PA, Handberg A, et al.
    TSH-receptor antibodies in early pregnancy.
    J Clin Endocrinol Metab 2022.

  4. Deek MP, Van der Eecken K, Sutera P, Deek RA, et al.
    Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials.
    J Clin Oncol 2022.

  5. Marques O, Weiss G, Muckenthaler MU.
    The role of iron in chronic inflammatory diseases - from mechanisms to treatment options in Anemia of Inflammation.
    Blood 2022.

  1. Long MT, Noureddin M, Lim JK.
    AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.
    Gastroenterology 2022;163:764-774.e1.

  2. Jaschinski N, Greenberg L, Neesgaard B, Miro JM, et al.
    Recent abacavir use and incident cardiovascular disease in contemporary treated people living with HIV.
    AIDS 2022.

  3. Piovani D, Hassan C, Repici A, Rimassa L, et al.
    Risk of Cancer in Inflammatory Bowel Diseases: Umbrella Review and Reanalysis of Meta-analyses.
    Gastroenterology 2022;163:671-684.

  4. Tosserams A, Keijsers N, Kapelle W, Kessels RPC, et al.
    Evaluation of Compensation Strategies for Gait Impairment in Patients With Parkinson Disease.
    Neurology 2022.

  5. Sarraj A, Albers GW, Blasco J, Arenillas JF, et al.
    Thrombectomy vs Medical Management in Mild Strokes due to Large Vessel Occlusion: Exploratory Analysis from the EXTEND-IA Trials and a Pooled International Cohort.
    Ann Neurol 2022.

  1. Rugo HS, Bardia A, Marme F, Cortes J, et al.
    Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.
    J Clin Oncol 2022.

  2. Brownlee WJ, Wolf C, Hartung HP, Dingermann T, et al.
    Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations.
    Mult Scler 2022.

  3. De Jong A, Myatra SN, Roca O, Jaber S, et al.
    How to improve intubation in the intensive care unit. Update on knowledge and devices.
    Intensive Care Med 2022.

  4. Rostamzadeh A, Bohr L, Wagner M, Baethge C, et al.
    Progression of Subjective Cognitive Decline to MCI or Dementia in Relation to Biomarkers for Alzheimer Disease: A Meta-Analysis.
    Neurology 2022.

  5. Sehjal J, Sharples LD, Keogh RH, Walker K, et al.
    Time-varying Comparison of All-cause Mortality After Liver Transplantation Between Recipients With and Without Hepatocellular Carcinoma: A Population-based Cohort Study Using the United Kingdom Liver Transplant Registry.
    Transplantation 2022.


more..


Privacy Policy